BTB01303

Overview

BTB01303 is a ( glutamate release ) inhibitor. Cancer cells release high levels of ( glutamate ), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain.

Application

Products | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Others | Products > Signaling Pathways > mGluR

Product Information

• Catalog No.: HY-153691
• CAS No.: 652129-89-0
• Molecular Formula: C15H11Cl2NO3
• Molecular Weight: 324.16
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source